Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-2718

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-2718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2718 1)

Label for Ondansetron ODT 8 mg orally disintegrating tablets from NuCare Pharmaceuticals, Inc. The carton indicates a quantity of 10 tablets with NDC 68071-2718-1. Instructions mention to see the manufacturer's label for ingredients. Includes storage instructions to keep at controlled temperature 68-77°F and a warning to keep out of reach of children.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure-base (Structure Base)

Chemical structure of the active ingredient Ondansetron, showing its molecular framework including a fused aromatic ring system and heterocyclic moieties.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, the active ingredient in Ondansetron 8 mg orally disintegrating tablets by NuCare Pharmaceuticals, Inc. The structure shows a complex heterocyclic compound with attached HCl and two water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.